Basem Al-Shayeb
Researcher / From Wikipedia, the free encyclopedia
Basem Al-Shayeb, is the founder and former Chief Technology Officer[1][2] of Amber Bio, which aims to develop multi-kilobase RNA editing therapies and has raised $26 million in funding. [3][4][5][6] He is a researcher at the Innovative Genomics Institute.[7] He led the discovery of the largest known bacteriophages,[8][9][10][11] the smallest CRISPR gene editing systems,[12][13][14][15] and Borgs in methane-oxidizing archaea.[16][17][18][19][20] He was named Forbes 30 Under 30 and Arab America's 30 Under 30. [21][22]